Home › Ewing Sarcoma › Utah › Salt Lake City
Ewing Sarcoma clinical trials in Salt Lake City, UT
4 studies for Ewing Sarcoma are looking for participants at sites in and around Salt Lake City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
RecruitingPhase 1
- Primary Children's Hospital, Salt Lake City
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RecruitingPhase 1/2
- Intermountain - Primary Children's Hospital ( Site 1014), Salt Lake City
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RecruitingPhase 1/2
- Primary Children's Hospital, Salt Lake City
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
RecruitingPhase 2
- Primary Children's Hospital, Salt Lake City
Ewing Sarcoma trials in other cities
- New York City, NY8 studies
- Houston, TX7 studies
- Philadelphia, PA7 studies
- Memphis, TN7 studies
- Washington, DC6 studies
- Boston, MA6 studies
- Los Angeles, CA6 studies
- Aurora, CO6 studies
- Atlanta, GA5 studies
- Birmingham, AL5 studies
- Columbus, OH4 studies
- Tampa, FL4 studies
Other studies in Salt Lake City
- Non-Small Cell Lung Cancer31 studies
- Cancer (all types)27 studies
- Breast Cancer27 studies
- Colorectal Cancer21 studies
- Lung Cancer21 studies
- Multiple Myeloma21 studies
- Melanoma21 studies
- Metastatic Cancer20 studies
- Ovarian Cancer19 studies
- Obesity18 studies
- Acute Myeloid Leukemia17 studies
- Heart Failure17 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.